This press release contains forward-looking statements related to the timing of the announcement of the results from cohort 4 of the Company’s Phase 1 clinical trial evaluating soquelitinib in ...
Cash constraints are forcing Corvus Pharmaceuticals to clip the wings of its lead candidate. Rather than advance on multiple fronts, the biotech is focusing on cancers including T-cell lymphoma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results